The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication
- PMID: 16585471
- PMCID: PMC1958997
- DOI: 10.1001/archpsyc.63.4.415
The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication
Abstract
Context: Only limited information exists about the epidemiology of DSM-IV panic attacks (PAs) and panic disorder (PD).
Objective: To present nationally representative data about the epidemiology of PAs and PD with or without agoraphobia (AG) on the basis of the US National Comorbidity Survey Replication findings.
Design and setting: Nationally representative face-to-face household survey conducted using the fully structured World Health Organization Composite International Diagnostic Interview.
Participants: English-speaking respondents (N=9282) 18 years or older.
Main outcome measures: Respondents who met DSM-IV lifetime criteria for PAs and PD with and without AG.
Results: Lifetime prevalence estimates are 22.7% for isolated panic without AG (PA only), 0.8% for PA with AG without PD (PA-AG), 3.7% for PD without AG (PD only), and 1.1% for PD with AG (PD-AG). Persistence, lifetime number of attacks, and number of years with attacks increase monotonically across these 4 subgroups. All 4 subgroups are significantly comorbid with other lifetime DSM-IV disorders, with the highest odds for PD-AG and the lowest for PA only. Scores on the Panic Disorder Severity Scale are also highest for PD-AG (86.3% moderate or severe) and lowest for PA only (6.7% moderate or severe). Agoraphobia is associated with substantial severity, impairment, and comorbidity. Lifetime treatment is high (from 96.1% for PD-AG to 61.1% for PA only), but 12-month treatment meeting published treatment guidelines is low (from 54.9% for PD-AG to 18.2% for PA only).
Conclusion: Although the major societal burden of panic is caused by PD and PA-AG, isolated PAs also have high prevalence and meaningful role impairment.
Figures
References
-
- Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994;51:8–19. - PubMed
-
- Eaton WW, Kessler RC, Wittchen HU, Magee WJ. Panic and panic disorder in the United States. Am J Psychiatry. 1994;151:413–420. - PubMed
-
- Sheikh JI, Leskin GA, Klein DF. Gender differences in panic disorder: findings from the National Comorbidity Survey. Am J Psychiatry. 2002;159:55–58. - PubMed
-
- Burke KC, Burke JD, Regier DA, Rae DA. Age of onset of selected mental disorders in five community populations. Arch Gen Psychiatry. 1990;47:511–518. - PubMed
-
- Kessler RC. The prevalence of psychiatric comorbidity. In: Wetzler S, Sanderson WC, editors. Treatment Strategies for Patients with Psychiatric Comorbidity. New York, NY: John Wiley & Sons; 1997.
Publication types
MeSH terms
Grants and funding
- R01 DA016558/DA/NIDA NIH HHS/United States
- U01-MH60220/MH/NIMH NIH HHS/United States
- R03 TW006481/TW/FIC NIH HHS/United States
- R01 MH069864/MH/NIMH NIH HHS/United States
- R01-DA016558/DA/NIDA NIH HHS/United States
- R01-MH069864/MH/NIMH NIH HHS/United States
- K05 DA015799/DA/NIDA NIH HHS/United States
- U01 MH060220/MH/NIMH NIH HHS/United States
- R13-MH066849/MH/NIMH NIH HHS/United States
- R01 MH070884/MH/NIMH NIH HHS/United States
- U13 MH066849/MH/NIMH NIH HHS/United States
- R01-TW006481/TW/FIC NIH HHS/United States
- R13 MH066849/MH/NIMH NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous